Spots Global Cancer Trial Database for small cell cancer of the lung
Every month we try and update this database with for small cell cancer of the lung cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of AZD2811 + Durvalumab in ES-SCLC | NCT04745689 | Small-Cell Lung... | Durvalumab AZD2811 Carboplatin Cisplatin Etoposide | 18 Years - 130 Years | AstraZeneca | |
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) | NCT03043872 | Small Cell Lung... | Durvalumab Tremelimumab Carboplatin Cisplatin Etoposide | 18 Years - 130 Years | AstraZeneca | |
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) | NCT03043872 | Small Cell Lung... | Durvalumab Tremelimumab Carboplatin Cisplatin Etoposide | 18 Years - 130 Years | AstraZeneca | |
Study of AZD2811 + Durvalumab in ES-SCLC | NCT04745689 | Small-Cell Lung... | Durvalumab AZD2811 Carboplatin Cisplatin Etoposide | 18 Years - 130 Years | AstraZeneca |